[A case of hepatitis B virus-related hepatocellular carcinoma with low-level viremia achieved seronegative conversion with entecavir combined with tenofovir amibufenamide].
Year: 2024
Type: article
Study design: Case Report
Abstract: 肝细胞癌（HCC）是严重威胁人们健康的高发肿瘤。乙型肝炎病毒（HBV）感染是导致HCC最主要的危险因素，抗病毒治疗可以改善肝功能，预防病毒再激活，降低HCC根治性治疗后的复发率，从而改善HBV 相关HCC患者预后。现报道1例HBV相关HCC患者，在进行抗肿瘤治疗期间，采用恩替卡韦联合艾米替诺福韦抗病毒治疗，实现低病毒血症阴转；减少HBV引起的肝脏损伤并阻止疾病进展，并提供良好的肝功能基础；降低HCC治疗后肿瘤复发风险，延长患者生存时间。.
Source: PubMed
Authors: W G Ren, J Li, S X Zhao, L D Liu, X X Zhang, Y M Nan
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4407800666